Lovastatin Protects against Experimental Plague in Mice

Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al. · 2010

Read Lovastatin Protects against Experimental Plague in Mice by Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010928.txt.

Description

Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez and co-authors published this plague study in PLOS ONE in 2010. Plague, caused by the bacterium Yersinia pestis, still kills people yearly in parts of Africa and is classed as a bioterrorism threat. Standard preventive antibiotics face resistant strains, so the team looked for a backup in an unlikely place: a cholesterol drug.

Lovastatin, already known to ease the symptoms of severe infection, was given to mice daily for six days before they were challenged with plague bacteria. Treated and untreated control groups let the authors judge whether pre-treatment changed survival and disease course. Ayyadurai and colleagues test the idea that a cheap, widely available statin could serve as extra protection after exposure. A positive result would matter most where resistant plague strains appear.

Catalog record

CREATORSaravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010928

Browse the full library · About the Tower of Babel